ArticleBMC cancer2026
The causal association between systolic blood pressure and breast cancer: a two sample Mendelian randomization study.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundBreast cancer (BC) is the leading cause of cancer incidence worldwide. Observational studies have suggested that hypertension may be a risk factor for BC. We tested whether systolic blood pressure (SBP) may influence BC and BC subtypes using a Mendelian randomisation (MR) approach.
methodsWe used 334 genetic variants associated with SBP as an instrumental variable. Effect estimates were obtained from the UK biobank (n = 469,767; SNP-exposure estimates) and the Breast Cancer Association Consortium (BCAC) (122,977 cases and 105,974 controls; SNP-outcome estimates). We assessed BC sub-types including: Triple-negative breast cancer (TNBC), human epidermal growth factor receptor 2 (HER2) positive, Luminal-A, Luminal-B, and Luminal-B HER2 negative. We used inverse variance weighted (IVW) as our primary analysis but conducted a series of sensitivity analyses to test the robustness of our findings. We created a restricted subset of SNPs by excluding SNPs associated with body mass index (BMI) and those with small effect sizes on the exposure, we also conducted multivariable mendelian randomisation analysis to control for adiposity as a potential confounder.
resultsFor each 1 mm/Hg increase in SBP the estimated effect was OR 1.00 (0.93, 1.08) for overall BC, analyses of BC sub-types results also did not support a causal effect of SBP. Similarly, results of our sensitivity analyses did not show strong evidence of an association.
conclusionThe results of our study did not support a causal effect of SBP on overall BC or its sub-types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.